Product Information
FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Mylan Institutional LLC, priced at $42.7121 per ML under NDC 67457058406. Its NADAC has been published 544 times since May 20, 2015.
FDA first approved this application on Dec 7, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
7.5 mg/.6mL
Manufacturer
Mylan Institutional LLCNDC
67457058406
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Authorized Generic (NDA)
FDA Application
NDA021345FDA Approved
12/7/2001
TE Code
AP
On Market Since
1/5/2015
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 544 times since May 20, 2015, and over the history we have for it it has declined 67.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.7121 per ML |
|---|---|
| All-time high | $129.7260 (Jun 10, 2015) |
| All-time low | $34.9283 (Jun 19, 2024) |
| 52-week high | $43.4533 |
| 52-week low | $38.5660 |
| Median price | $67.7570 |
| Average price | $68.5779 |
| Largest weekly change | -30.5% (Jul 20, 2016) |
| Weeks tracked | 544 |
| Tracking since | May 20, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Mylan Institutional LLC, is $42.7121 per ML (NDC 67457058406), effective Aug 19, 2026.
How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 67.1%. It has been tracked across 544 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?
Since May 20, 2015, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $129.7260 (Jun 10, 2015), with a median of $67.7570 per ML.
Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 7.5 MG/0.6 ML SYR, is $20.9233 per ML — about 51% below FONDAPARINUX 7.5 MG/0.6 ML SYR.
Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?
FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 67457058406) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.